Skip to main content
Article thumbnail
Location of Repository

Tumor associated antigens in diagnosis of serous effusions

By Alexander L. Gerbes, J. Mezger, W. Permanetter, W. Wilmanns and R. Lamerz


The use of tumour associated antigens in the diagnosis of serous effusions was studied in 76 patients with benign and 200 patients with malignant disease. Tissue polypeptide antigen (TPA), alpha fetoprotein, and CA 125 were found to be of little value. At cut off points of 3 ng/ml, 10 U/ml, and 30 U/ml, respectively, carcinoembryonic antigen (CEA), biliary glycoprotein I (BGP I), and CA 19-9 discriminated between benign and malignant serous effusions with a sensitivity of between 24% and 67%. The immunocytochemical staining for these markers resulted in malignant cells being detected in 18% to 33% of cases. Various combinations of conventional cytological examination, effusion fluid tumour marker determination, and immunocytochemical analysis identified malignant cells in serous effusions in up to 72% of cases; conventional cytology alone detected tumour cells in only 30%.

Topics: Medizin, ddc:610
Year: 1988
DOI identifier: 10.1136/jcp.41.6.633
OAI identifier:
Provided by: Open Access LMU

Suggested articles


  1. 36:1154-64.Tumour associatedantigens in diagnosis ofserous effusions 643
  2. 9) localization in 121 primary and metastatic ovarian tumors: an immunohistochemical study with the use ofmonoclonal antibodies.
  3. A new marker for humancancercells. 3. Immunocytochemical detection ofmalignant cells in serous fluids with the Cal antibody. Lancet
  4. A pitfall in immunocytochemistry-non specific staining ofplasmacytoid cells with indirect immunocytochemical techniques. J Tumor Marker Oncol 1988;3:
  5. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.
  6. Absence of carcinoembryonic antigen-like material in mesothelioma.
  7. Analysis of ascitic fluid in cirrhosis.
  8. Antigene carcinoembryonnaire dans les ascites et les epanchements pleuraux.
  9. Ascites IV. Clinical appraisal ofthe laboratory studies ofascitic fluid and blood as an aid to diagnosis.
  10. (1976). Bestimmungen von karzinoembryonalem Antigen bei Patienten mit Dickdarmtumoren. Munch Med Wochenschr
  11. (1977). Bradwell AR.Cancerassociated proteins in effusion fluids.
  12. Ca2andCa 3. Newmonoclonal antibodiesevaluated as tumor markers in serous effusions.
  13. Carcinoembryonic antigen assay of ascites and detection of malignancy.
  14. Carcinoembryonic antigen in pleural effusions.
  15. Carcinoembryonic antigen levels in benign and malignant pleural effusions.
  16. Carcinoembryonic antigen levels in malignant pleural fluids obtained from patients with mammary cancer.
  17. Carcinoembryonic antigen titers on effusion fluid.
  18. Carcinoembryonic antigen-like substances ofhuman bile. Isolation and partial characterization.
  19. (1979). Characteristics ofascitic fluid in the alcoholic cirrhotic. Dig Dis Sci
  20. Coexpression of simple epithelial keratins and vimentin by human mesothelium and mesothelioma in vivo and in culture.
  21. Combined effusion fluid tumor marker assay, carcinoembryonic antigen (CEA) and human chorionic gonadotrophin (hCG), in the detection of malignant tumors.
  22. (1978). Concurrent assays of plasma and pleural-effusion levels ofcarcinoembryonic antigen in the diagnosis ofpulmonary disease. Lancet
  23. Crosslinked fibrin derivatives and fibronectin in ascitic fluid from patients with ovarian cancer compared to ascitic fluid in liver cirrhosis.
  24. Diagnostic significance of carcinoembryonic antigen levels in serous effusions.
  25. Diagnostic value of ascitic fluid lacticdehydrogenase, protein andWBC levels.
  26. Diagnostic value of lactic acid dehydrogenase activity determination in ascitic fluid.
  27. Diagnostic value of tumoral markers in serous effusions.
  28. Diagnostic value oftheestimation ofglucose in ascitic fluid.
  29. Diagnostischer Stellenwert des carcinoembryonalen Antigens im Pleurapunktat. Dtsch Med Wochenschr
  30. Diagnostischer Wert laborchemischer Aszitesuntersuchungen.
  31. (1979). Direct visualization ofnormal crossreactingantigen(NCA) in normal and neoplastic granulocytes. Lab Invest
  32. Distribution oftissue polypeptide antigen in normal and neoplastic tissues.
  33. Elevation of CA 125 in patients with benign and malignant ascites. Cancer 1987;59:213-7. Requests for reprints to:
  34. (1983). Experience with the Oxford tumour marker (Cal) in serous fluids. Lancet
  35. F.Carcinoembryonic antigen (CEA) and relatedantigensin bloodcellsandhematopoietic tissue.
  36. Fibronectin concentration in ascites differentiates between malignant and nonmalignant ascites.
  37. High protein ascites in patients with uncomplicatedhepaticcirrhosis.
  38. Immunocytochemical detection of carcinoembryonic antigen in conventional histopathology specimens.
  39. Immunocytochemical staining ofcells inpleural andperitoneal effusions with a panel ofmonoclonal antibodies.
  40. Immunocytochemical stainingwithmonoclonal antibodiesincytologically"negative" serous effusions from patients with malignant disease.
  41. Immunohistochemical studies in effusion sediments of lysozyme, alpha-l-antitrypsin, tissue polypeptide antigen (TPA), keratin and carcinoembryonic antigen(CEA).
  42. Immunopathologic characterization ofa monoclonal antibody that recognizes common surface antigens of human ovarian tumors ofserous, endometrioid, and clear cell types.
  43. Keratin ofdifferent molecular weight in exfoliated mesothelial and adenocarcinoma cells-an aid to cell identification.
  44. (1981). Measurement of lactate in asciticfluid. An aid in thediagnosisofperitonitis with particular relevance to spontaneous bacterial peritonitis ofthe cirrhotic. Dig Dis Sci
  45. (1986). Occurrence of biliary glycoprotein-like antigen (BGP I) in normal and adult, inflammatory and cancerous tissues. TumorBiology
  46. Oncofetal antigens as tumor markers in thecytologicdiagnosis ofeffusions.
  47. Overview ofTPA: specificity, immunocytochemistry and biological basis.
  48. Quantification of carcinoembryonic antigen-like activities in normal human gastrointestinal secretions. Cancer 1975;36:
  49. (1986). Radioimmunological detection of biliary glycoprotein-likeantigen(BGPI)inseraofhealthysubjectsand patients with benign and malignant gastrointestinal diseases. Twnor Biology
  50. (1983). Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clin Chem
  51. Reactivity ofa monoclonal antibody with human ovarian carcinoma.
  52. Serum-ascites albumin concentration gradient: A physiological approach to thedifferential diagnosis ofascites.
  53. Simultaneous enzyme immunoassay ofcarcinoemrbryonic antigen in pleural effusion and serum.
  54. Statistical significance of carcinoembryonic antigen in plasma and pleural fluid. Surgery
  55. The pH ofascitic fluid in the diagnosis of spontaneous bacterial peritonitis in alcoholic cirrhosis.
  56. The significance of bloody ascites in patients with cirrhosis.
  57. The value ofserum concentrations oftissue polypeptide antigen in the diagnosis of hepatocellular carcinoma.
  58. Tissue distribution of a coelomic epitheliumrelated antigen recognized by themonoclonal antibody OC125.
  59. Tissue polypeptide antigen (TPA) in pancreatic cancer diagnosis.
  60. Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions.
  61. Useofa monoclonal antibody (B72-3) as an immunocytochemical adjunct to diagnosis of adenocarcinoma in human effusions.
  62. Useofantisera toepithelialmemb~raneantigen for the cytodiagnosis of malignancy in serous effusions.
  63. Value ofascitic lipids in the differentiation between cirrhotic and malignant ascites.
  64. ZGM and EMA localization in cells of pleural and peritoneal effusion: A preliminary study.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.